These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

316 related items for PubMed ID: 1965151

  • 21. Regulation of human squamous cell carcinoma plasma membrane associated urokinase plasminogen activator by epidermal growth factor.
    Niedbala MJ, Bajetta S, Carbone R, Sartorelli AC.
    Cancer Commun; 1990; 2(9):317-24. PubMed ID: 2169831
    [Abstract] [Full Text] [Related]

  • 22. Urokinase plasminogen activator induces human smooth muscle cell migration and proliferation via distinct receptor-dependent and proteolysis-dependent mechanisms.
    Stepanova V, Mukhina S, Köhler E, Resink TJ, Erne P, Tkachuk VA.
    Mol Cell Biochem; 1999 May; 195(1-2):199-206. PubMed ID: 10395084
    [Abstract] [Full Text] [Related]

  • 23. Assembly of urokinase receptor-mediated plasminogen activation complexes involves direct, non-active-site interactions between urokinase and plasminogen.
    Ellis V, Whawell SA, Werner F, Deadman JJ.
    Biochemistry; 1999 Jan 12; 38(2):651-9. PubMed ID: 9888805
    [Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26. Identification and characterization of human endothelial cell membrane binding sites for tissue plasminogen activator and urokinase.
    Hajjar KA, Hamel NM.
    J Biol Chem; 1990 Feb 15; 265(5):2908-16. PubMed ID: 2154465
    [Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28. Regulation and role of urokinase plasminogen activator in vascular remodelling.
    Tkachuk V, Stepanova V, Little PJ, Bobik A.
    Clin Exp Pharmacol Physiol; 1996 Sep 15; 23(9):759-65. PubMed ID: 8911711
    [Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35. Keratinocyte urokinase-type plasminogen activator is secreted as a single chain precursor.
    Hashimoto K, Prystowsky JH, Baird J, Lazarus GS, Jensen PJ.
    J Invest Dermatol; 1988 Jun 15; 90(6):823-8. PubMed ID: 2967334
    [Abstract] [Full Text] [Related]

  • 36. Neuronal plasminogen activators: cell surface binding sites and involvement in neurite outgrowth.
    Pittman RN, Ivins JK, Buettner HM.
    J Neurosci; 1989 Dec 15; 9(12):4269-86. PubMed ID: 2512375
    [Abstract] [Full Text] [Related]

  • 37. In vivo paracrine interaction between urokinase and its receptor: effect on tumor cell invasion.
    Ossowski L, Clunie G, Masucci MT, Blasi F.
    J Cell Biol; 1991 Nov 15; 115(4):1107-12. PubMed ID: 1659573
    [Abstract] [Full Text] [Related]

  • 38. Urokinase and tissue type plasminogen activators in human keratinocyte culture.
    Jensen PJ, John M, Baird J.
    Exp Cell Res; 1990 Mar 15; 187(1):162-9. PubMed ID: 2105225
    [Abstract] [Full Text] [Related]

  • 39. The urokinase-receptor (CD87) is expressed in cells of the megakaryoblastic lineage.
    Wohn KD, Kanse SM, Deutsch V, Schmidt T, Eldor A, Preissner KT.
    Thromb Haemost; 1997 Mar 15; 77(3):540-7. PubMed ID: 9066008
    [Abstract] [Full Text] [Related]

  • 40. Generation of cell surface-bound plasmin by cell-associated urokinase-type or secreted tissue-type plasminogen activator: a key event in melanoma cell invasiveness in vitro.
    Meissauer A, Kramer MD, Schirrmacher V, Brunner G.
    Exp Cell Res; 1992 Apr 15; 199(2):179-90. PubMed ID: 1531956
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 16.